Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 22, 2013 - Issue 8
Submit an article Journal homepage
306
Views
15
CrossRef citations to date
0
Altmetric
Drug Evaluations

Sorafenib for ovarian cancer

Umberto Leone Roberti MaggioreUniversity of Genoa, San Martino Hospital and National Institute for Cancer Research, Department of Obstetrics and Gynecology, Largo R. Benzi 1, 16132 Genoa, Italy+01139 010511525; +01139 010511525; [email protected]
, MD,
Mario Valenzano MenadaUniversity of Genoa, San Martino Hospital and National Institute for Cancer Research, Department of Obstetrics and Gynecology, Largo R. Benzi 1, 16132 Genoa, Italy+01139 010511525; +01139 010511525; [email protected]
, MD,
Pier Luigi VenturiniUniversity of Genoa, San Martino Hospital and National Institute for Cancer Research, Department of Obstetrics and Gynecology, Largo R. Benzi 1, 16132 Genoa, Italy+01139 010511525; +01139 010511525; [email protected]
, MD &
Simone FerreroUniversity of Genoa, San Martino Hospital and National Institute for Cancer Research, Department of Obstetrics and Gynecology, Largo R. Benzi 1, 16132 Genoa, Italy+01139 010511525; +01139 010511525; [email protected]
, MD PhD
Pages 1049-1062 | Published online: 15 May 2013

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Alice Bergamini, Simone Ferrero, Umberto Leone Roberti Maggiore, Carolina Scala, Francesca Pella, Valerio Gaetano Vellone, Micaela Petrone, Emanuela Rabaiotti, Raffaella Cioffi, Massimo Candiani & Giorgia Mangili. (2016) Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer. Expert Opinion on Investigational Drugs 25:12, pages 1405-1412.
Read now
Umberto Leone Roberti Maggiore & Simone Ferrero. (2016) An overview of early drug development for endometriosis. Expert Opinion on Investigational Drugs 25:2, pages 227-247.
Read now
Umberto Leone Roberti Maggiore, Mario Valenzano Menada, Pier Luigi Venturini & Simone Ferrero. (2013) The potential of sunitinib as a therapy in ovarian cancer. Expert Opinion on Investigational Drugs 22:12, pages 1671-1686.
Read now

Articles from other publishers (12)

Chae Eun Jin, Moon Sup Yoon, Min Jeong Jo, Seo Yeon Kim, Jae Min Lee, Su Jeong Kang, Chun-Woong Park, Jin-Seok Kim & Dae Hwan Shin. (2023) Synergistic Encapsulation of Paclitaxel and Sorafenib by Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles for Ovarian Cancer Therapy. Pharmaceutics 15:4, pages 1206.
Crossref
Hongyu Kong, Rong Zhang, Qinghe Jing, Yu Liang, Qiao Zhuo, Bo Li, Shujie Zhang, Weiliang Zhu & Chen Zhao. (2022) Intravitreal injection of EV11, a novel aryl ketone amide, inhibits choroidal neovascularization via AKT/ERK1/2 pathway. Microvascular Research 143, pages 104401.
Crossref
Chuntao Tian, Ying Liu, Lingfei Xue, Dong Zhang, Xiaotong Zhang, Jing Su, Jiaohong Chen, Xiangke Li, Liuxing Wang & Shunchang Jiao. (2022) Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial–mesenchymal transition. Open Life Sciences 17:1, pages 616-625.
Crossref
Vadabingi Nagalakshmamma, Mallepogu Venkataswamy, Chiranjeevi Pasala, Amineni Uma Maheswari, Kedam Thyaga Raju, Chamarthi Nagaraju & Ponne V. Chalapathi. (2021) A study on MAPK/ERK and CDK2-Cyclin-E signal switch “on and off” in cell proliferation by bis urea derivatives of 1, 4-Diisocyanatobenzene. Bioorganic Chemistry 112, pages 104940.
Crossref
Gabriella Ferrandina & Giacomo Corrado. (2018) Treatment of platinum refractory or resistant ovarian cancer. The Lancet Oncology 19:9, pages 1147-1149.
Crossref
Giorgio Bogani, Antonino Ditto, Fabio Martinelli, Mauro Signorelli, Valentina Chiappa, Caterina Fonatella, Roberta Sanfilippo, Umberto Leone Roberti Maggiore, Simone Ferrero, Domenica Lorusso & Francesco Raspagliesi. (2018) Role of bevacizumab in uterine leiomyosarcoma. Critical Reviews in Oncology/Hematology 126, pages 45-51.
Crossref
Mingming Miao, Guanming Deng, Sujuan Luo, Jiajia Zhou, Le Chen, Jun Yang, Jie He, Junjun Li, Jing Yao, Shanmei Tan & Jie Tang. (2018) A phase II study of apatinib in patients with recurrent epithelial ovarian cancer. Gynecologic Oncology 148:2, pages 286-290.
Crossref
Ashraf Kareem El-Damasy, Ju-Hyeon Lee, Seon Hee Seo, Nam-Chul Cho, Ae Nim Pae & Gyochang Keum. (2016) Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-RafV600E and C-Raf kinase inhibitory activities. European Journal of Medicinal Chemistry 115, pages 201-216.
Crossref
Ashraf Kareem El-Damasy, Seon Hee Seo, Nam-Chul Cho, Soon Bang Kang, Ae Nim Pae, Key-Sun Kim & Gyochang Keum. (2015) Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives. European Journal of Medicinal Chemistry 101, pages 754-768.
Crossref
Xiaoyun Yang, Fangrong Shen, Wei Hu, Robert L. Coleman & Anil K. Sood. (2015) New ways to successfully target tumor vasculature in ovarian cancer. Current Opinion in Obstetrics & Gynecology 27:1, pages 58-65.
Crossref
Bernd C. Schmid & Martin K. Oehler. (2015) Improvements in Progression-Free and Overall Survival Due to the Use of Anti-Angiogenic Agents in Gynecologic Cancers. Current Treatment Options in Oncology 16:1.
Crossref
Jean Pierre Spinosa & Darja Kanduc. (2014) Ovarian cancer: designing effective vaccines and specific diagnostic tools. Immunotherapy 6:1, pages 35-41.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.